| Engerix-B |
103239 |
001 |
351(a) |
Hepatitis B Vaccine (Recombinant) |
Injection |
Intramuscular |
20UG/ML |
Pre-Filled Syringe |
1989/08/28
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Engerix-B |
103239 |
002 |
351(a) |
Hepatitis B Vaccine (Recombinant) |
Injection |
Intramuscular |
20UG/ML |
Single-Dose Vial |
1989/08/28
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Engerix-B |
103239 |
003 |
351(a) |
Hepatitis B Vaccine (Recombinant) |
Injection |
Intramuscular |
10UG/.5ML |
Pre-Filled Syringe |
1989/08/28
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Engerix-B |
103239 |
004 |
351(a) |
Hepatitis B Vaccine (Recombinant) |
Injection |
Intramuscular |
10UG/.5ML |
Single-Dose Vial |
1989/08/28
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Tice Bcg |
102821 |
001 |
351(a) |
BCG Live |
For Injection |
Intravesical |
100-800 MIL CFU |
Single-Dose Vial |
1989/06/21
|
Merck Teknika LLC |
Rx |
Licensed |
|
N/A |
|
103050 |
001 |
351(a) |
BCG Vaccine |
For Injection |
Percutaneous |
100-800 MIL CFU |
Single-Dose Vial |
1989/06/21
|
Merck Teknika LLC |
Rx |
Licensed |
|
N/A |
| Epogen/Procrit |
103234 |
001 |
351(a) |
epoetin alfa |
Injection |
Intravenous, Subcutaneous |
10,000UNITS/ML |
Single-Dose Vial |
1989/06/01
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Epogen/Procrit |
103234 |
004 |
351(a) |
epoetin alfa |
Injection |
Intravenous, Subcutaneous |
2,000UNITS/ML |
Single-Dose Vial |
1989/06/01
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Epogen/Procrit |
103234 |
005 |
351(a) |
epoetin alfa |
Injection |
Intravenous, Subcutaneous |
3,000UNITS/ML |
Single-Dose Vial |
1989/06/01
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Epogen/Procrit |
103234 |
007 |
351(a) |
epoetin alfa |
Injection |
Intravenous, Subcutaneous |
4,000UNITS/ML |
Single-Dose Vial |
1989/06/01
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Humulin 70/30 |
019717 |
001 |
351(a) |
insulin isophane human and insulin human |
Injectable Suspension |
Subcutaneous |
700UNITS/10ML (70UNITS/ML); 300UNITS/10ML (30UNITS/ML) |
Multi-Dose Vial |
1989/04/25
|
Eli Lilly and Company |
OTC |
Licensed |
N/A |
N/A |
| Humulin 70/30 |
019717 |
002 |
351(a) |
insulin isophane human and insulin human |
Injectable Suspension |
Subcutaneous |
210UNITS/3ML (70UNITS/ML); 90UNITS/3ML (30UNITS/ML) |
Multi-Dose Vial |
1989/04/25
|
Eli Lilly and Company |
OTC |
Licensed |
N/A |
N/A |
| Draximage MAA |
017881 |
001 |
351(a) |
kit for the preparation of technetium Tc-99m albumin aggregated |
For Injectable Suspension |
Intravenous |
2.5MG/5MG/0.6MG/ 1.2MG |
Multi-Dose Vial |
1987/12/30
|
Jubilant DraxImage Inc. |
Rx |
Licensed |
N/A |
N/A |
| prolastin,prolastin-c,prolastin-c liquid |
103174 |
001 |
351(a) |
Alpha-1-Proteinase Inhibitor (Human) |
For Injection |
Intravenous |
1000MG |
Single-Dose Vial |
1987/12/02
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| prolastin,prolastin-c,prolastin-c liquid |
103174 |
002 |
351(a) |
Alpha-1-Proteinase Inhibitor (Human) |
For Injection |
Intravenous |
500MG |
Single-Dose Vial |
1987/12/02
|
Grifols Therapeutics LLC |
Disc |
Licensed |
|
N/A |
| Activase |
103172 |
001 |
351(a) |
alteplase |
For Injection |
Intravenous |
50MG |
Single-Dose Vial |
1987/11/13
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Activase |
103172 |
002 |
351(a) |
alteplase |
For Injection |
Intravenous |
100MG |
Single-Dose Vial |
1987/11/13
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
001 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
2MG |
Single-Dose Vial |
1987/06/23
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
004 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
5MG |
Single-Dose Vial |
1986/10/16
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Recombivax, Recombivax Hb |
101066 |
001 |
351(a) |
Hepatitis B Vaccine (Recombinant) |
Injection |
Intramuscular |
5UG/ML |
Single-Dose Vial |
1986/07/23
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |